Table of Contents Chapter 1 Overview of Becker Muscular Dystrophy Drug 1.1 Definition of Becker Muscular Dystrophy Drug in This Report 1.2 Commercial Types of Becker Muscular Dystrophy Drug 1.2.1 Givinostat 1.2.2 Ataluren 1.2.3 Epicatechin 1.2.4 ARM-210 1.2.5 Others 1.3 Downstream Application of Becker Muscular Dystrophy Drug 1.3.1 Hospital 1.3.2 Clinic 1.3.3 Others 1.4 Development History of Becker Muscular Dystrophy Drug 1.5 Market Status and Trend of Becker Muscular Dystrophy Drug 2013-2023 1.5.1 Global Becker Muscular Dystrophy Drug Market Status and Trend 2013-2023 1.5.2 Regional Becker Muscular Dystrophy Drug Market Status and Trend 2013-2023 Chapter 2 Global Market Status and Forecast by Regions 2.1 Market Development of Becker Muscular Dystrophy Drug 2013-2017 2.2 Production Market of Becker Muscular Dystrophy Drug by Regions 2.2.1 Production Volume of Becker Muscular Dystrophy Drug by Regions 2.2.2 Production Value of Becker Muscular Dystrophy Drug by Regions 2.3 Demand Market of Becker Muscular Dystrophy Drug by Regions 2.4 Production and Demand Status of Becker Muscular Dystrophy Drug by Regions 2.4.1 Production and Demand Status of Becker Muscular Dystrophy Drug by Regions 2013-2017 2.4.2 Import and Export Status of Becker Muscular Dystrophy Drug by Regions 2013-2017 Chapter 3 Global Market Status and Forecast by Types 3.1 Production Volume of Becker Muscular Dystrophy Drug by Types 3.2 Production Value of Becker Muscular Dystrophy Drug by Types 3.3 Market Forecast of Becker Muscular Dystrophy Drug by Types Chapter 4 Global Market Status and Forecast by Downstream Industry 4.1 Demand Volume of Becker Muscular Dystrophy Drug by Downstream Industry 4.2 Market Forecast of Becker Muscular Dystrophy Drug by Downstream Industry Chapter 5 Market Driving Factor Analysis of Becker Muscular Dystrophy Drug 5.1 Global Economy Situation and Trend Overview 5.2 Becker Muscular Dystrophy Drug Downstream Industry Situation and Trend Overview Chapter 6 Becker Muscular Dystrophy Drug Market Competition Status by Major Manufacturers 6.1 Production Volume of Becker Muscular Dystrophy Drug by Major Manufacturers 6.2 Production Value of Becker Muscular Dystrophy Drug by Major Manufacturers 6.3 Basic Information of Becker Muscular Dystrophy Drug by Major Manufacturers 6.3.1 Headquarters Location and Established Time of Becker Muscular Dystrophy Drug Major Manufacturer 6.3.2 Employees and Revenue Level of Becker Muscular Dystrophy Drug Major Manufacturer 6.4 Market Competition News and Trend 6.4.1 Merger, Consolidation or Acquisition News 6.4.2 Investment or Disinvestment News 6.4.3 New Product Development and Launch Chapter 7 Becker Muscular Dystrophy Drug Major Manufacturers Introduction and Market Data 7.1 Italfarmaco SpA 7.1.1 Company profile 7.1.2 Representative Becker Muscular Dystrophy Drug Product 7.1.3 Becker Muscular Dystrophy Drug Sales, Revenue, Price and Gross Margin of Italfarmaco SpA 7.2 Milo Biotechnology LLC 7.2.1 Company profile 7.2.2 Representative Becker Muscular Dystrophy Drug Product 7.2.3 Becker Muscular Dystrophy Drug Sales, Revenue, Price and Gross Margin of Milo Biotechnology LLC 7.3 PTC Therapeutics Inc 7.3.1 Company profile 7.3.2 Representative Becker Muscular Dystrophy Drug Product 7.3.3 Becker Muscular Dystrophy Drug Sales, Revenue, Price and Gross Margin of PTC Therapeutics Inc 7.4 ReveraGen BioPharma Inc 7.4.1 Company profile 7.4.2 Representative Becker Muscular Dystrophy Drug Product 7.4.3 Becker Muscular Dystrophy Drug Sales, Revenue, Price and Gross Margin of ReveraGen BioPharma Inc 7.5 Sarepta Therapeutics Inc 7.5.1 Company profile 7.5.2 Representative Becker Muscular Dystrophy Drug Product 7.5.3 Becker Muscular Dystrophy Drug Sales, Revenue, Price and Gross Margin of Sarepta Therapeutics Inc Chapter 8 Upstream and Downstream Market Analysis of Becker Muscular Dystrophy Drug 8.1 Industry Chain of Becker Muscular Dystrophy Drug 8.2 Upstream Market and Representative Companies Analysis 8.3 Downstream Market and Representative Companies Analysis Chapter 9 Cost and Gross Margin Analysis of Becker Muscular Dystrophy Drug 9.1 Cost Structure Analysis of Becker Muscular Dystrophy Drug 9.2 Raw Materials Cost Analysis of Becker Muscular Dystrophy Drug 9.3 Labor Cost Analysis of Becker Muscular Dystrophy Drug 9.4 Manufacturing Expenses Analysis of Becker Muscular Dystrophy Drug Chapter 10 Marketing Status Analysis of Becker Muscular Dystrophy Drug 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.1.3 Marketing Channel Development Trend 10.2 Market Positioning 10.2.1 Pricing Strategy 10.2.2 Brand Strategy 10.2.3 Target Client 10.3 Distributors/Traders List Chapter 11 Report Conclusion Chapter 12 Research Methodology and Reference 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Reference

List of Tables Table Advantage and Disadvantage of Givinostat Table Advantage and Disadvantage of Ataluren Table Advantage and Disadvantage of Epicatechin Table Advantage and Disadvantage of ARM-210 Table Advantage and Disadvantage of Others Table Production Volume of Becker Muscular Dystrophy Drug by Regions 2013-2017 Table Production Value of Becker Muscular Dystrophy Drug by Regions 2013-2017 Table Demand Volume of Becker Muscular Dystrophy Drug by Regions 2013-2017 Table Production and Demand Status of Becker Muscular Dystrophy Drug in Region One 2013-2017 Table Production and Demand Status of Becker Muscular Dystrophy Drug in Region Two 2013-2017 Table Production and Demand Status of Becker Muscular Dystrophy Drug in Region Three 2013-2017 Table Production and Demand Status of Becker Muscular Dystrophy Drug in Region Four 2013-2017 Table Import Volume of Becker Muscular Dystrophy Drug by Regions 2013-2017 Table Export Volume of Becker Muscular Dystrophy Drug by Regions 2013-2017 Table Production Volume of Becker Muscular Dystrophy Drug by Types 2013-2017 Table Production Value of Becker Muscular Dystrophy Drug by Types 2013-2017 Table Production Volume Forecast of Becker Muscular Dystrophy Drug by Types 2018-2023 Table Production Value Forecast of Becker Muscular Dystrophy Drug by Types 2018-2023 Table Demand Volume of Becker Muscular Dystrophy Drug by Downstream Industry 2013-2017 Table Demand Volume Forecast of Becker Muscular Dystrophy Drug by Downstream Industry 2018-2023 Table Production Volume of Becker Muscular Dystrophy Drug by Major Manufacturers 2013-2017 Table Production Value of Becker Muscular Dystrophy Drug by Major Manufacturers 2013-2017 Table Headquarters Location and Established Time of Becker Muscular Dystrophy Drug Major Manufacturer Table Employees and Revenue Level of Becker Muscular Dystrophy Drug Major Manufacturer Table Representative Becker Muscular Dystrophy Drug Product One of Italfarmaco SpA Table Representative Becker Muscular Dystrophy Drug Product Two of Italfarmaco SpA Table Becker Muscular Dystrophy Drug Sales, Revenue, Price and Gross Margin of Italfarmaco SpA 2013-2017 Table Representative Becker Muscular Dystrophy Drug Product One of Milo Biotechnology LLC Table Representative Becker Muscular Dystrophy Drug Product Two of Milo Biotechnology LLC Table Becker Muscular Dystrophy Drug Sales, Revenue, Price and Gross Margin of Milo Biotechnology LLC 2013-2017 Table Representative Becker Muscular Dystrophy Drug Product One of PTC Therapeutics Inc Table Representative Becker Muscular Dystrophy Drug Product Two of PTC Therapeutics Inc Table Becker Muscular Dystrophy Drug Sales, Revenue, Price and Gross Margin of PTC Therapeutics Inc 2013-2017 Table Representative Becker Muscular Dystrophy Drug Product One of ReveraGen BioPharma Inc Table Representative Becker Muscular Dystrophy Drug Product Two of ReveraGen BioPharma Inc Table Becker Muscular Dystrophy Drug Sales, Revenue, Price and Gross Margin of ReveraGen BioPharma Inc 2013-2017 Table Representative Becker Muscular Dystrophy Drug Product One of Sarepta Therapeutics Inc Table Representative Becker Muscular Dystrophy Drug Product Two of Sarepta Therapeutics Inc Table Becker Muscular Dystrophy Drug Sales, Revenue, Price and Gross Margin of Sarepta Therapeutics Inc 2013-2017